Skip to main content
. Author manuscript; available in PMC: 2018 Jul 31.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):556–563. doi: 10.1097/QAI.0000000000001143

Table 2.

Multivariable risk factors for condomless sex acts in the past 30 days. TDF2 clinical trial, Botswana 2007–2010.

Demographic
Characteristic or
Risk Behavior
No condomless sex acts ≥1 condomless sex acts
Odds
Ratio
95% CI p-value RateRatio 95% CI p-value
Time (per year) 1.23 1.10, 1.37 .0002 0.98 0.89, 1.11 .6910
Treatment Arm
Perception
  TDF 1.05 0.77, 1.44 .7422 0.95 0.73, 1.24 .7135
  Not Sure 1.06 0.80, 1.38 .6967 0.89 0.70, 1.11 .2954
  Placebo REF REF
Sexual Debut
  15 or less 0.37 0.23, 0.61 <.0001 1.65 1.14, 2.38 .0081
  16–17 0.49 0.32, 0.72 .0005 1.68 1.22, 2.31 .0016
  18–19 0.72 0.50, 1.04 .0857 1.34 1.00, 1.81 .0551
  20+ REF REF
Gender
  Female -- -- -- REF
  Male -- -- -- 1.34 1.07, 1.67 .0100
STI
  Yes 0.43 0.27, 0.69 .0003 -- -- --
  No REF -- -- --
HSV-2
  Yes -- -- -- 1.32 1.06, 1.66 .0147
  No -- -- -- REF

Note: “—“ indicates the variable was not included in that component of the final multivariable model.